The Procter & Gamble Company(PG)Earnings, Financials & Key Ratios

PG•NYSE

$147.93

$345.67B mkt cap·22.7× P/E·Price updated May 6, 2026

SectorConsumer Defensive IndustryHousehold Products Sub-IndustryHousehold Cleaning and Paper Goods

AboutThe Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.Show more

Revenue$84.28B+0.3%
EBITDA$23.3B+8.7%
Net Income$15.97B+7.4%
EPS (Diluted)6.51+8.1%
Gross Margin51.16%-0.5%
EBITDA Margin27.64%+8.3%
Operating Margin24.26%+10.0%
Net Margin18.95%+7.0%
ROE31.07%+1.9%
ROIC20.1%+7.4%
Debt/Equity0.68+2.8%
Interest Coverage23.23+9.2%

Analysis→Technical→

PG Key Insights

The Procter & Gamble Company (PG) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Dividend Aristocrat: 36 years of consecutive increases
✓Excellent 3Y average ROE of 30.9%
✓FCF machine: 16.7% free cash flow margin
✓Healthy dividend yield of 2.7%
✓Healthy 5Y average net margin of 18.3%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

PG Price & Volume

The Procter & Gamble Company (PG) stock price & volume — 10-year historical chart

Loading chart...

PG Growth Metrics

The Procter & Gamble Company (PG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years1.77%

5 Years3.5%

3 Years1.67%

TTM3.33%

Profit CAGR

10 Years8.54%

5 Years4.16%

3 Years2.71%

TTM-17.94%

EPS CAGR

10 Years10.31%

5 Years5.59%

3 Years3.86%

TTM8.57%

Return on Capital

10 Years17.51%

5 Years21.47%

3 Years21.92%

Last Year22.99%

PG Recent Earnings

The Procter & Gamble Company (PG) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 11/12 qtrs (92%)●Beat Revenue 6/12 qtrs (50%)

Q2 2026Latest

Apr 24, 2026

EPS

$1.59

Est $1.56

+1.9%

Revenue

$21.2B

Est $20.5B

+3.4%

Q1 2026

Jan 22, 2026

EPS

$1.88

Est $1.86

+1.1%

Revenue

$22.2B

Est $22.3B

-0.4%

Q4 2025

Oct 24, 2025

EPS

$1.99

Est $1.90

+4.7%

Revenue

$22.4B

Est $22.2B

+0.9%

Q3 2025

Jul 29, 2025

EPS

$1.48

Est $1.42

+4.2%

Revenue

$20.9B

Est $20.8B

+0.2%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 24, 2026	$1.59vs $1.56+1.9%	$21.2Bvs $20.5B+3.4%
Q1 2026	Jan 22, 2026	$1.88vs $1.86+1.1%	$22.2Bvs $22.3B-0.4%
Q4 2025	Oct 24, 2025	$1.99vs $1.90+4.7%	$22.4Bvs $22.2B+0.9%
Q3 2025	Jul 29, 2025	$1.48vs $1.42+4.2%	$20.9Bvs $20.8B+0.2%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
ULUnilever PLCDirect Competitor	130.44B	59.70	22.21	1.94%	10.16%	61.19%	1.36
KMBKimberly-Clark CorporationDirect Competitor	32.93B	99.19	16.34	-14.17%	12.81%	131.68%	4.34
CLColgate-Palmolive CompanyDirect Competitor	70.73B	88.16	33.52	1.4%	10.46%	251.59%	21.88
CHDChurch & Dwight Co., Inc.Direct Competitor	22.49B	94.96	31.44	1.57%	11.81%	17.45%	0.55
ENREnergizer Holdings, Inc.Direct Competitor	1.3B	18.97	5.71	2.28%	6.55%	116.9%	20.79
ELThe Estée Lauder Companies Inc.Product Competitor	31.29B	86.67	-27.51	-8.46%	-1.67%	-6.29%	2.44
REYNReynolds Consumer Products Inc.Product Competitor	4.62B	21.91	15.32	0.7%	8.7%	14.88%	0.78
SPBSpectrum Brands Holdings, Inc.Product Competitor	1.98B	85.03	22.03	-5.23%	3.76%	5.52%	0.34

Compare PG vs Peers

The Procter & Gamble Company (PG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs UL

Most directly comparable listed peer for PG.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare PG against a more recognizable public peer.

Peer Set

Compare Top 5

vs UL, KMB, CL, CHD

PG Income Statement

The Procter & Gamble Company (PG) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Sales/Revenue	65.06B	66.83B	67.68B	70.95B	76.12B	80.19B	82.01B	84.04B	84.28B	86.72B
Revenue Growth %	-0.37%	2.73%	1.27%	4.83%	7.28%	5.35%	2.27%	2.48%	0.29%	3.33%
Cost of Goods Sold	32.64B	34.43B	34.77B	35.25B	37.11B	42.16B	42.76B	40.85B	41.16B	43.07B
COGS % of Revenue	50.17%	51.52%	51.37%	49.68%	48.75%	52.57%	52.14%	48.61%	48.84%	-
Gross Profit	32.42B▲ 0%	32.4B▼ 0.1%	32.92B▲ 1.6%	35.7B▲ 8.5%	39.01B▲ 9.3%	38.03B▼ 2.5%	39.25B▲ 3.2%	43.19B▲ 10.1%	43.12B▼ 0.2%	43.64B▲ 0%
Gross Margin %	49.83%	48.48%	48.63%	50.32%	51.25%	47.43%	47.86%	51.39%	51.16%	50.33%
Gross Profit Growth %	0.09%	-0.06%	1.59%	8.46%	9.27%	-2.51%	3.2%	10.05%	-0.16%	-
Operating Expenses	18.65B	19.04B	27.43B	19.99B	21.02B	20.22B	21.11B	24.65B	22.67B	23.49B
OpEx % of Revenue	28.67%	28.48%	40.53%	28.18%	27.62%	25.21%	25.74%	29.33%	26.9%	-
Selling, General & Admin	18.65B	19.04B	19.08B	19.99B	21.02B	20.22B	21.11B	23.3B	22.67B	23.49B
SG&A % of Revenue	28.67%	28.48%	28.2%	28.18%	27.62%	25.21%	25.74%	27.73%	26.9%	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	8.35B	0	0	0	0	1.34B	0	-1000K
Operating Income	13.77B▲ 0%	13.36B▼ 2.9%	5.49B▼ 58.9%	15.71B▲ 186.2%	17.99B▲ 14.5%	17.81B▼ 1.0%	18.13B▲ 1.8%	18.55B▲ 2.3%	20.45B▲ 10.3%	20.15B▲ 0%
Operating Margin %	21.16%	19.99%	8.11%	22.14%	23.63%	22.21%	22.11%	22.07%	24.26%	23.24%
Operating Income Growth %	2.42%	-2.93%	-58.94%	186.24%	14.52%	-0.96%	1.8%	2.27%	10.28%	-
EBITDA	16.59B	16.2B	8.31B	18.72B	20.72B	20.62B	20.85B	21.44B	23.3B	21.87B
EBITDA Margin %	25.49%	24.24%	12.28%	26.38%	27.22%	25.71%	25.42%	25.51%	27.64%	25.22%
EBITDA Growth %	0.41%	-2.35%	-48.69%	125.23%	10.7%	-0.49%	1.11%	2.84%	8.66%	-4.35%
D&A (Non-Cash Add-back)	2.82B	2.83B	2.82B	3.01B	2.73B	2.81B	2.71B	2.9B	2.85B	1.48B
EBIT	13.72B	13.83B	6.58B	16.3B	18.12B	18.43B	19.11B	19.69B	21.07B	16.57B
Net Interest Income	-294M	-259M	-289M	-310M	-457M	-388M	-449M	-452M	-438M	138M
Interest Income	171M	247M	220M	155M	45M	51M	307M	473M	469M	427M
Interest Expense	465M	506M	509M	465M	502M	439M	756M	925M	907M	-34M
Other Income/Expense	-509M	-37M	582M	128M	-371M	182M	219M	216M	-284M	812M
Pretax Income	13.26B▲ 0%	13.33B▲ 0.5%	6.07B▼ 54.5%	15.83B▲ 160.9%	17.61B▲ 11.2%	18B▲ 2.2%	18.35B▲ 2.0%	18.76B▲ 2.2%	20.17B▲ 7.5%	20.96B▲ 0%
Pretax Margin %	20.38%	19.94%	8.97%	22.32%	23.14%	22.44%	22.38%	22.32%	23.93%	24.18%
Income Tax	3.06B	3.46B	2.1B	2.73B	3.26B	3.2B	3.62B	3.79B	4.1B	8.21B
Effective Tax Rate %	23.1%	26%	34.65%	17.25%	18.52%	17.79%	19.7%	20.19%	20.34%	39.15%
Net Income	15.33B▲ 0%	9.75B▼ 36.4%	3.9B▼ 60.0%	13.03B▲ 234.3%	14.31B▲ 9.8%	14.74B▲ 3.0%	14.65B▼ 0.6%	14.88B▲ 1.5%	15.97B▲ 7.4%	12.72B▲ 0%
Net Margin %	23.56%	14.59%	5.76%	18.36%	18.79%	18.38%	17.87%	17.7%	18.95%	14.66%
Net Income Growth %	45.85%	-36.38%	-60.03%	234.28%	9.82%	3.05%	-0.6%	1.54%	7.36%	-17.94%
Net Income (Continuing)	10.19B	9.86B	3.97B	13.1B	14.35B	14.79B	14.74B	14.97B	16.07B	12.76B
Discontinued Operations	5.22B	0	0	0	0	0	0	0	0	0
Minority Interest	594M	590M	385M	357M	276M	265M	288M	272M	272M	0
EPS (Diluted)	5.59▲ 0%	3.67▼ 34.3%	1.43▼ 61.0%	4.96▲ 246.9%	5.50▲ 10.9%	5.81▲ 5.6%	5.90▲ 1.5%	6.02▲ 2.0%	6.51▲ 8.1%	5.26▲ 0%
EPS Growth %	51.49%	-34.35%	-61.04%	246.85%	10.89%	5.64%	1.55%	2.03%	8.14%	8.57%
EPS (Basic)	5.80	3.75	1.45	5.13	5.69	6.00	6.07	6.18	6.67	-
Diluted Shares Outstanding	2.74B	2.66B	2.54B	2.63B	2.6B	2.54B	2.48B	2.47B	2.45B	2.42B
Basic Shares Outstanding	2.6B	2.53B	2.5B	2.54B	2.51B	2.46B	2.37B	2.36B	2.45B	2.42B
Dividend Payout Ratio	47.21%	74.97%	192.4%	59.79%	57.76%	59.49%	61.41%	62.58%	61.8%	-

PG Balance Sheet

The Procter & Gamble Company (PG) balance sheet — assets, liabilities & shareholders' equity

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Total Current Assets	26.49B	23.32B	22.47B	27.99B	23.09B	21.65B	22.65B	24.71B	25.39B	27.99B
Cash & Short-Term Investments	15.14B	11.85B	10.29B	16.18B	10.29B	7.21B	8.25B	9.48B	9.56B	12.31B
Cash Only	5.57B	2.57B	4.24B	16.18B	10.29B	7.21B	8.25B	9.48B	9.56B	12.31B
Short-Term Investments	9.57B	9.28B	6.05B	0	0	0	0	0	0	0
Accounts Receivable	4.59B	4.69B	4.95B	4.18B	4.72B	5.14B	5.47B	6.12B	6.18B	6.32B
Days Sales Outstanding	25.77	25.59	26.7	21.49	22.66	23.41	24.35	26.57	26.78	26.59
Inventory	4.62B	4.74B	5.02B	5.5B	5.98B	6.92B	7.07B	7.02B	7.55B	7.85B
Days Inventory Outstanding	51.71	50.23	52.67	56.93	58.85	59.95	60.38	62.69	66.95	65.82
Other Current Assets	2.14B	2.05B	2.22B	2.13B	0	2.37B	1.86B	2.09B	2.1B	1.51B
Total Non-Current Assets	93.91B	94.99B	92.62B	92.71B	96.22B	95.56B	98.18B	97.66B	99.84B	100.39B
Property, Plant & Equipment	19.89B	20.6B	21.27B	20.69B	21.69B	21.2B	21.91B	22.15B	23.9B	24.57B
Fixed Asset Turnover	3.27x	3.24x	3.18x	3.43x	3.51x	3.78x	3.74x	3.79x	3.53x	3.57x
Goodwill	44.7B	45.17B	40.27B	39.9B	40.92B	39.7B	40.66B	40.3B	41.65B	41.36B
Intangible Assets	24.19B	23.9B	24.21B	23.79B	23.64B	23.68B	23.78B	22.05B	21.91B	21.53B
Long-Term Investments	0	0	0	0	192M	140M	0	0	0	0
Other Non-Current Assets	5.13B	5.31B	6.86B	8.33B	9.77B	10.84B	11.83B	13.16B	12.38B	51.02B
Total Assets	120.41B▲ 0%	118.31B▼ 1.7%	115.09B▼ 2.7%	120.7B▲ 4.9%	119.31B▼ 1.2%	117.21B▼ 1.8%	120.83B▲ 3.1%	122.37B▲ 1.3%	125.23B▲ 2.3%	128.38B▲ 0%
Asset Turnover	0.54x	0.56x	0.59x	0.59x	0.64x	0.68x	0.68x	0.69x	0.67x	0.68x
Asset Growth %	-5.29%	-1.74%	-2.72%	4.87%	-1.15%	-1.76%	3.09%	1.28%	2.34%	11.4%
Total Current Liabilities	30.21B	28.24B	30.01B	32.98B	33.13B	33.08B	35.76B	33.63B	36.06B	38.23B
Accounts Payable	9.63B	10.34B	11.26B	12.07B	13.72B	14.88B	14.6B	15.36B	15.23B	15.03B
Days Payables Outstanding	107.72	109.65	118.21	124.99	134.95	128.85	124.61	137.29	135.02	129.31
Short-Term Debt	13.55B	10.42B	9.7B	11.18B	8.89B	8.64B	10.23B	7.19B	9.51B	13.17B
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	3.6B	3.97B	4.41B	5.26B	5.53B	4.88B	5.75B	5.33B	5.74B	25.06B
Current Ratio	0.88x	0.83x	0.75x	0.85x	0.70x	0.65x	0.63x	0.73x	0.70x	0.70x
Quick Ratio	0.72x	0.66x	0.58x	0.68x	0.52x	0.45x	0.44x	0.53x	0.49x	0.49x
Cash Conversion Cycle	-30.23	-33.83	-38.84	-46.57	-53.45	-45.49	-39.88	-48.02	-41.28	-36.9
Total Non-Current Liabilities	34.42B	37.19B	37.51B	40.85B	39.52B	37.27B	38.01B	38.19B	36.89B	35.41B
Long-Term Debt	18.04B	20.86B	20.39B	23.54B	23.1B	22.85B	24.38B	25.27B	25B	23.85B
Capital Lease Obligations	38M	85M	0	652M	631M	595M	595M	666M	701M	701M
Deferred Tax Liabilities	8.13B	6.16B	6.9B	6.2B	6.15B	6.81B	6.48B	6.52B	5.77B	23.69B
Other Non-Current Liabilities	8.22B	10.08B	10.21B	10.46B	9.64B	7.02B	6.56B	5.73B	5.42B	22.5B
Total Liabilities	64.63B	65.43B	67.52B	73.82B	72.65B	70.35B	73.76B	71.81B	72.95B	73.65B
Total Debt	31.64B	31.39B	30.1B	35.61B	32.84B	32.29B	35.42B	33.37B	35.46B	37.03B
Net Debt	26.07B	28.82B	25.86B	19.43B	22.55B	25.08B	27.18B	23.89B	25.91B	24.72B
Debt / Equity	0.57x	0.59x	0.63x	0.76x	0.70x	0.69x	0.75x	0.66x	0.68x	0.68x
Debt / EBITDA	1.91x	1.94x	3.62x	1.90x	1.58x	1.57x	1.70x	1.56x	1.52x	1.69x
Net Debt / EBITDA	1.57x	1.78x	3.11x	1.04x	1.09x	1.22x	1.30x	1.11x	1.11x	1.11x
Interest Coverage	29.51x	27.34x	12.92x	35.05x	36.09x	41.99x	25.28x	21.28x	23.23x	-487.21x
Total Equity	55.78B▲ 0%	52.88B▼ 5.2%	47.58B▼ 10.0%	46.88B▼ 1.5%	46.65B▼ 0.5%	46.85B▲ 0.4%	47.06B▲ 0.5%	50.56B▲ 7.4%	52.28B▲ 3.4%	54.73B▲ 0%
Equity Growth %	-3.8%	-5.19%	-10.03%	-1.47%	-0.48%	0.43%	0.45%	7.42%	3.41%	13.92%
Book Value per Share	20.35	19.91	18.74	17.85	17.94	18.45	18.95	20.45	21.30	22.65
Total Shareholders' Equity	55.18B	52.29B	47.19B	46.52B	46.38B	46.59B	46.78B	50.29B	52.01B	54.73B
Common Stock	4.01B	4.01B	4.01B	4.01B	4.01B	4.01B	4.01B	4.01B	4.01B	0
Retained Earnings	96.12B	98.64B	94.92B	100.24B	106.37B	112.43B	118.17B	123.81B	129.97B	135.42B
Treasury Stock	-93.72B	-99.22B	-100.41B	-105.57B	-114.97B	-123.38B	-129.74B	-133.38B	-138.7B	0
Accumulated OCI	-14.63B	-14.75B	-14.94B	-16.16B	-13.74B	-12.19B	-12.22B	-11.9B	-12.14B	-12.3B
Minority Interest	594M	590M	385M	357M	276M	265M	288M	272M	272M	0

PG Cash Flow Statement

The Procter & Gamble Company (PG) cash flow — operating, investing & free cash flow history

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Cash from Operations	12.75B	14.87B	15.24B	17.4B	18.37B	16.72B	16.85B	19.85B	17.82B	17.82B
Operating CF Margin %	19.6%	22.25%	22.52%	24.53%	24.13%	20.86%	20.54%	23.62%	21.14%	-
Operating CF Growth %	-17.38%	16.58%	2.52%	14.18%	5.56%	-8.97%	0.75%	17.79%	-10.22%	24.57%
Net Income	15.33B	9.86B	3.97B	13.1B	14.35B	14.79B	14.74B	14.88B	16.07B	12.72B
Depreciation & Amortization	2.82B	2.83B	2.82B	3.01B	2.73B	2.81B	2.71B	2.9B	2.85B	3.07B
Stock-Based Compensation	366M	395M	515M	558M	540M	528M	545M	562M	476M	506M
Deferred Taxes	-601M	-1.84B	-411M	-596M	-258M	-402M	-453M	-244M	149M	144M
Other Non-Cash Items	-4.71B	601M	7.98B	115M	631M	144M	524M	2.19B	755M	-3.46B
Working Capital Changes	-443M	3.02B	368M	1.21B	371M	-1.15B	-1.22B	-436M	-2.47B	2.46B
Change in Receivables	-322M	-177M	-276M	634M	-342M	-694M	-307M	-766M	45M	-62M
Change in Inventory	71M	-188M	-239M	-637M	-309M	-1.25B	-119M	-70M	-324M	-261M
Change in Payables	-149M	1.39B	1.86B	1.92B	1.39B	1.43B	313M	1.81B	-542M	1.32B
Cash from Investing	-6.68B	-3.51B	-3.49B	3.04B	-2.83B	-4.42B	-3.5B	-3.5B	-3.82B	-4.49B
Capital Expenditures	-3.38B	-3.72B	-3.35B	-3.07B	-2.79B	-3.16B	-3.06B	-3.32B	-3.77B	-4.38B
CapEx % of Revenue	5.2%	5.56%	4.95%	4.33%	3.66%	3.94%	3.73%	3.95%	4.48%	-
Acquisitions	-491M	-109M	-3.94B	-58M	-34M	-1.38B	-765M	-21M	-11M	-85M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	571M	269M	394M	30M	42M	110M	327M	-161M	-34M	-24M
Cash from Financing	-8.57B	-14.38B	-9.99B	-8.37B	-21.53B	-14.88B	-12.15B	-14.86B	-14.04B	-11.77B
Debt Issued (Net)	1.4B	-1.24B	-817M	4.85B	-3.9B	1.89B	2.94B	-2.44B	630M	1.62B
Equity Issued (Net)	-5.2B	-7B	-5B	-7.41B	-11.01B	-10B	-7.35B	-5.01B	-4.79B	-4.23B
Dividends Paid	-7.24B	-7.31B	-7.5B	-7.79B	-8.26B	-8.77B	-9B	-9.31B	-9.87B	-10.18B
Share Repurchases	-5.2B	-7B	-5B	-7.41B	-11.01B	-10B	-7.35B	-5.01B	-6.5B	-4.85B
Other Financing	2.47B	1.18B	3.32B	1.98B	1.64B	2B	1.27B	1.91B	-1M	1.02B
Net Change in Cash	-1.53B▲ 0%	-3B▼ 95.7%	1.67B▲ 155.7%	11.94B▲ 615.1%	-5.89B▼ 149.3%	-3.07B▲ 47.8%	1.03B▲ 133.6%	1.24B▲ 19.8%	74M▼ 94.0%	3.19B▲ 0%
Free Cash Flow	9.37B▲ 0%	11.15B▲ 19.0%	11.89B▲ 6.7%	14.33B▲ 20.5%	15.58B▲ 8.8%	13.57B▼ 12.9%	13.79B▲ 1.6%	16.52B▲ 19.9%	14.04B▼ 15.0%	15.03B▲ 0%
FCF Margin %	14.4%	16.68%	17.57%	20.2%	20.47%	16.92%	16.81%	19.66%	16.66%	17.33%
FCF Growth %	-22.7%	19.01%	6.68%	20.47%	8.75%	-12.94%	1.61%	19.86%	-15.01%	0.02%
FCF per Share	3.42	4.20	4.68	5.46	5.99	5.34	5.55	6.68	5.72	5.72
FCF Conversion (FCF/Net Income)	0.83x	1.52x	3.91x	1.34x	1.28x	1.13x	1.15x	1.33x	1.12x	1.18x
Interest Paid	518M	529M	497M	434M	531M	451M	721M	878M	896M	0
Taxes Paid	3.71B	2.83B	3.06B	3.55B	3.82B	3.82B	4.28B	4.36B	4.55B	0

PG Key Ratios

The Procter & Gamble Company (PG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	26.94%	17.95%	7.76%	27.58%	30.59%	31.53%	31.2%	30.48%	31.07%	23.78%
Return on Invested Capital (ROIC)	12.64%	12.26%	5.3%	16.86%	19.91%	18.93%	18.61%	18.71%	20.1%	20.1%
Gross Margin	49.83%	48.48%	48.63%	50.32%	51.25%	47.43%	47.86%	51.39%	51.16%	50.33%
Net Margin	23.56%	14.59%	5.76%	18.36%	18.79%	18.38%	17.87%	17.7%	18.95%	14.66%
Debt / Equity	0.57x	0.59x	0.63x	0.76x	0.70x	0.69x	0.75x	0.66x	0.68x	0.68x
Interest Coverage	29.51x	27.34x	12.92x	35.05x	36.09x	41.99x	25.28x	21.28x	23.23x	-487.21x
FCF Conversion	0.83x	1.52x	3.91x	1.34x	1.28x	1.13x	1.15x	1.33x	1.12x	1.18x
Revenue Growth	-0.37%	2.73%	1.27%	4.83%	7.28%	5.35%	2.27%	2.48%	0.29%	3.33%

PG SEC Filings & Documents

The Procter & Gamble Company (PG) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 24, 2026·SEC

Material company update

Apr 24, 2026·SEC

Material company update

Apr 14, 2026·SEC

10-K Annual Reports

FY 2025

Aug 4, 2025·SEC

10-Q Quarterly Reports

FY 2026

Apr 24, 2026·SEC

FY 2026

Jan 23, 2026·SEC

FY 2025

Oct 24, 2025·SEC

PG Frequently Asked Questions

The Procter & Gamble Company (PG) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

The Procter & Gamble Company (PG) reported $86.72B in revenue for fiscal year 2025. This represents a 146% increase from $35.28B in 1996.

The Procter & Gamble Company (PG) grew revenue by 0.3% over the past year. Growth has been modest.

Yes, The Procter & Gamble Company (PG) is profitable, generating $12.72B in net income for fiscal year 2025 (19.0% net margin).

Dividend & Returns

Yes, The Procter & Gamble Company (PG) pays a dividend with a yield of 2.72%. This makes it attractive for income-focused investors.

The Procter & Gamble Company (PG) has a return on equity (ROE) of 31.1%. This is excellent, indicating efficient use of shareholder capital.

The Procter & Gamble Company (PG) generated $15.03B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More PG

The Procter & Gamble Company (PG) financial analysis — history, returns, DCA and operating performance tools

Full PG Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

The Procter & Gamble Company(PG)Earnings, Financials & Key Ratios

PG Key Insights

✓Strengths

✗Weaknesses

PG Price & Volume

PG Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

PG Recent Earnings

PG Peer Comparison

Compare PG vs Peers

vs UL

vs AMZN

Compare Top 5

PG Income Statement

PG Balance Sheet

PG Cash Flow Statement

PG Key Ratios

PG SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

PG Frequently Asked Questions

Explore More PG

Full PG Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation